Medlife Pharmacy and Compounding, Inc., Irvine, CA
Is Medlife Pharmacy and Compounding, Inc. registered with the FDA as a 503B outsourcing facility?
No matching record found in FDA’s registered outsourcing facility list (updated Nov 6, 2026) on Nov 15, 2026, searching by name and location. FDA’s compounding inspections and actions page labels it a 503A facility.
Does Medlife Pharmacy and Compounding, Inc. hold a California pharmacy license?
The California State Board of Pharmacy lists license PHY 51156 for Medlife Pharmacy & Compounding, Irvine, status Active, as of Nov 6, 2026.
Has Medlife Pharmacy and Compounding, Inc. had a state board action or FDA letter?
FDA letters: record found. FDA’s compounding inspections and actions page, current as of Oct 22, 2026, lists 1 warning letter (Apr 24, 2020), 1 warning letter close-out (Nov 29, 2021), 1 state handoff letter (Nov 29, 2021) and 1 FMD-145 letter (Nov 29, 2021) for Medlife Pharmacy and Compounding, Inc. State board actions: no California State Board of Pharmacy action on license PHY 51156 or under this exact name and city was found in the board’s posted disciplinary decisions on facility licenses (actions dated Jan 5, 2005 to Oct 28, 2026) on Nov 6, 2026. The state referral and handoff letters above are FDA’s letters to the state, not board actions.
FDA registers 503B outsourcing facilities; state boards of pharmacy license pharmacies, including 503A compounding pharmacies, and keep their own disciplinary records. Neither FDA list says which drugs a pharmacy makes.
- Names in FDA records
- Medlife Pharmacy and Compounding, Inc.
- Location
- Irvine, CA
- Type as FDA labels it
- 503A
- FDA 503B list
- No matching record found
- Form 483s on FDA’s actions page
- 0
- Warning letters on FDA’s actions page
- 1
- Latest action on that page
- Nov 29, 2021
- FDA Data Dashboard inspections
- 0 inspections; 0 published Form 483s
- State board records
- License found: PHY 51156, Active
FDA inspections and letters
FDA’s compounding inspections and actions page (current as of Oct 22, 2026) lists this pharmacy as Medlife Pharmacy and Compounding, Inc., a 503A facility, with 4 dated actions.
| Document | |||
|---|---|---|---|
| Nov 29, 2021 | State handoff letter | State Handoff Letter Issued 11/29/2021 | Not linked by FDA |
| Nov 29, 2021 | FMD-145 letter | FMD-145 Letter Issued 11/29/2021 | Not linked by FDA |
| Nov 29, 2021 | Warning letter close-out | Warning Letter Close Out Issued 11/29/2021 | Not linked by FDA |
| Apr 24, 2020 | Warning letter | Warning Letter (04/24/2020) | FDA copy (archived) |
A warning letter states FDA’s view when it was issued, not a court finding; any close-out letter FDA lists is a row of its own. An untitled or FMD-145 letter states FDA’s view when it was issued.
FDA inspection classifications and published Form 483s
The FDA Data Dashboard, read Nov 15, 2026, lists Medlife Pharmacy and Compounding, Irvine, CA (FEI number 3014332926), matched to this page by exact name, city and state. It lists no classified inspection under this name at that site. Dashboard firm profile.
Form 483s FDA has published for this site
No published Form 483 for FEI 3014332926 was found in the dashboard’s list of published 483s on Nov 15, 2026. FDA publishes only some 483s, so this does not mean none was issued.
FDA classifies each inspection when it is closed: No Action Indicated (NAI) means no objectionable conditions were found or they did not justify further action; Voluntary Action Indicated (VAI) means objectionable conditions were found but FDA is not prepared to take or recommend regulatory action; Official Action Indicated (OAI) means FDA recommended regulatory or administrative action. A classification is FDA’s, not a finding by this site. The dashboard lists inspections once FDA has classified them, from fiscal year 2009 on, so a recent inspection may not appear yet.
State board of pharmacy records
The California State Board of Pharmacy file dated Nov 6, 2026 lists these licenses under the same name, city and state as this pharmacy. Board file.
| License | Type as the board gives it | Name on the board record | City | Status |
|---|---|---|---|---|
| PHY 51156 | Retail Pharmacy | Medlife Pharmacy & Compounding | Irvine | Active |
What this covers: Facility license decisions from the board’s quarterly Disciplinary Actions pages (87 of 88 quarters had a facility section). These are final decisions; accusations filed and immediate protection orders are not included. Actions in the data are dated Jan 5, 2005 to Oct 28, 2026.
This page restates FDA’s lists and state board of pharmacy records. A Form 483, letter or board action is not a finding by this site, and a missing record is not a finding either way. A state license is matched only on the same name, city and state. Follow each link for the original document. Report an error or add a company response.
Sources
- FDA: Compounding: Inspections, Recalls, and other Actions
- FDA Registered Outsourcing Facilities (503B)
- FDA Data Dashboard: inspection classifications and published Form 483s
- California State Board of Pharmacy license file
- California State Board of Pharmacy disciplinary records
Records last pulled Nov 15, 2026. Every entry links to the original public record.